Sonoran Biosciences is an early stage pharmaceutical company that has developed SB Gel, the first viscous sustained release carrier.
Sonoran Biosciences has raised $260K in total funding. The most recent round was Grant. The last funding was announced in September 2022.
Sonoran Biosciences's investors include Small Business Innovation Research.
Sonoran Biosciences is headquartered in Scottsdale, United States.
Sonoran Biosciences is an early stage pharmaceutical company that has developed SB Gel, the first viscous sustained release carrier.
Sonoran Biosciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sonoran Biosciences — Funding & Investors." VCBacked, September 6, 2022, https://www.vcbacked.co/company/sonoran-biosciences. Accessed November 12, 2026.
VCBacked. (2022). Sonoran Biosciences — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/sonoran-biosciences
{{cite web |title=Sonoran Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/sonoran-biosciences |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Sonoran Biosciences? Request a listing update